Using a mobile app to help older patients with blood cancers exercise more effectively
A novel mobile health exercise intervention for older patients with myeloid neoplasms
This study is for older adults with blood cancer who want to feel better and stay active; it’s testing a new mobile app that encourages exercise to help improve their strength and overall well-being.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10693908 on NIH RePORTER |
What this research studies
This research focuses on older adults diagnosed with myeloid neoplasms, a type of blood cancer, who often experience physical decline and symptoms like fatigue. The study aims to develop a mobile health application that encourages these patients to engage in exercise, thereby improving their physical function and overall quality of life. The app will help patients overcome barriers to exercise and enhance their confidence in maintaining an active lifestyle. Additionally, the research will investigate how this intervention affects certain inflammatory markers related to their condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 60 and above who have been diagnosed with myeloid neoplasms and are receiving outpatient treatment.
Not a fit: Patients who are younger than 60 or those who do not have myeloid neoplasms may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly enhance the quality of life for older patients with myeloid neoplasms by improving their physical function and reducing symptoms.
How similar studies have performed: Previous research has shown that mobile health interventions can effectively improve exercise adherence and health outcomes in older populations, suggesting a promising approach in this context.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Loh, Kah Poh — University of Rochester
- Study coordinator: Loh, Kah Poh
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.